Health
Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis – News-Medical.Net
A new study examines the associations between immunosuppressive disease-modifying therapies (DMTs) used in MS with adverse outcomes in an international cohort of…
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients with coexisting medical conditions have been noted to be at a higher risk of progressive and severe disease. Patients with multiple sclerosis (MS), who are often on immunosuppressive therapy, may be among these high-risk groups.
A new study, released on the medRxiv* preprint server, examines the associations between immunosuppressive disease-modifying…
-
General23 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Business17 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News16 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News13 hours agoTips to improve engagement – Proctor